Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to compare the use of a specific drug eluting balloon (Magic Touch, Concept Medical®) versus standard drug eluting stent based strategies in patients with long coronary lesions. Participants with chronic coronary disease and long coronary stenosis will be randomly assign to be treated either with Magic Touch balloon or drug eluting stent.


Clinical Trial Description

Patients at coronary angiography who are deemed suitable for PCI are assessed for eligibility. Patients fulfilling all inclusion and no exclusion criteria can be consented for trial participation. After successful lesion preparation, defined as residual stenosis less than 30%, TIMI flow 3 and no major (type C) dissection of target lesion, consented patients will be randomized in a 1:1 ratio to a drug eluting balloon(DEB)-based or standard drug eluting stent(DES)-based strategy and further randomized in a 1:1 fashion, stratified based on DEB vs DES, to undergo invasive follow-up at 6 (±30 days) or 12 (±30 days) months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05674630
Study type Interventional
Source Cardiocentro Ticino
Contact Marco Valgimigli, M.D., Ph.D
Phone +410918115111
Email marco.valgimigli@eoc.ch
Status Recruiting
Phase Phase 4
Start date February 21, 2023
Completion date December 1, 2030

See also
  Status Clinical Trial Phase
Recruiting NCT06185530 - SECURE Trial: Stress Echocardiography With Carotid Ultrasound vs Routine CT Coronary Angiography in Chronic Coronary Syndrome for Endpoints N/A
Recruiting NCT05117866 - Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study N/A
Recruiting NCT05727982 - Identification of Molecular Mechanisms of Coronary Instability in Homogeneous Subsets of Patients With Acute Coronary Syndromes for the Implementation of Precision Medicine
Completed NCT06464276 - Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study
Recruiting NCT03936504 - Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model N/A
Recruiting NCT05978089 - Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome(MET STUDY) Phase 4
Recruiting NCT05875311 - Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC) N/A
Recruiting NCT05865600 - Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome N/A
Recruiting NCT06337461 - Computational mOdelliNg of myoCardial pERfusion to Improve ouTcome Prediction Based on cOronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography
Recruiting NCT05640752 - Optimal Evaluation to Reduce Imaging Testing N/A
Recruiting NCT05635994 - Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
Recruiting NCT05583786 - Intracoronary ECG ST-segment Shift Remission Time During Reactive Coronary Hyperemia
Completed NCT05592535 - Outcomes With Fractional Flow Reserve in Chronic Coronary Syndrome
Recruiting NCT06255678 - Angio-based Final Functional Effect of PCI
Recruiting NCT06275399 - Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery
Not yet recruiting NCT06186336 - Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
Withdrawn NCT04738344 - Very Long Versus Overlapping Stents in Long Coronary Lesions N/A
Active, not recruiting NCT04135989 - Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES Phase 4
Recruiting NCT06171061 - Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome Phase 4
Recruiting NCT05379608 - Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection. N/A